News
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Rolly Bustos All right. I think to respect everybody’s time, I think we will get started here. So again, greetings, and welcome to all...
News
Fidelity’s mission is to strengthen the financial well-being of our customers and deliver better outcomes for the clients and businesses it serves. With assets...
News
Q1: 2026-05-06 Earnings Summary EPS of $0.30 beats by $0.02 | Revenue of $1.57B (37.93% Y/Y) misses by $309.50M This article was written by Follow...
News
The Biden administration has taken significant steps to establish a brand new student loan forgiveness plan. The new program is intended to be a...
News
The Obesity Investment Thesis Remains Impressive, Albeit Inflated Novo Nordisk (NVO) is a pharmaceutical company that does not need any introductions indeed, with Wegovy/Ozempic...
News
Since my previous article on Suzano S.A. (NYSE:SUZ), the leader in the pulp and paper industry, the company has released its second-quarter 2023 results....
News
With interest rates on the rise, it is no surprise that producers of high ticket consumer items (boats, RVs, cars) are under pressure. In...
News
Amazon (NASDAQ:AMZN) is set to report earnings for the third-quarter on October 26, 2023 and the current consolidation ahead of earnings actually let me...
News
For those who made investing in Amazon.com, Inc. (NASDAQ:AMZN) part of their New Year’s activities, the year has indeed been an exhilarating one, with...
News
Overview My recommendation for Watsco, Inc. (NYSE:WSO) is a hold rating, as my target price is currently at WSO’s traded share price. WSO has...
News
Like several cities in the Southern United States, Atlanta has experienced a surge in popularity as a place of work and residence. From a...
News
At a Glance Building on my previous analysis of Dynavax Technologies (NASDAQ:DVAX), the landscape has shifted subtly. HEPLISAV-B sales continue to be a bright...
